The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Grant | Alive

Total Raised


Last Raised

$50K | 3 yrs ago

About FloBio

FloBio is developing a point-of-care microfluidic chip and reader for rapid platelet function testing. Using minimal amounts of blood, the device will monitor anticoagulation pharmacology used in newborns undergoing corrective heart surgery, on life-sustaining circulatory, or pulmonary support.

FloBio Headquarter Location

3401 Grays Ferry Avenue Building 450

Philadelphia, Pennsylvania, 19146,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing FloBio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FloBio is included in 3 Expert Collections, including Medical Devices.


Medical Devices

7,913 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

701 items

Companies developing technology to facilitate near-patient and point-of-care (POC) in vitro diagnostic testing. Companies tagged as #NearPatient&POCTesting


Health IT

7,900 items

Latest FloBio News

4 pediatric medical device developers receive seed funds

May 9, 2019

4 pediatric medical device developers receive seed funds PPDC supports projects addressing point-of-care blood testing, tracheal dislodgement, peripheral intravenous catheters, respiratory distress syndrome. The pediatric medical devices are: Rapid platelet monitoring system for newborns Tracheostomy tube dislodgement alarm Negative-pressure non-invasive ventilator for newborn intensive care Funded by the U.S. Food and Drug Administration (FDA) and based at Children's Hospital of Philadelphia (CHOP) , the PPDC provides know-how and seed funding to help innovators translate promising ideas into commercial medical devices for use in children. The PPDC is a collaboration involving CHOP, the McGowan Institute for Regenerative Medicine and sciVelo , both of the University of Pittsburgh, Drexel University, and the University of Pennsylvania. The new round of awards is the sixth by the PPDC , following seed grants announced in February 2015, January 2016, January 2017, October 2017, and July 2018 . FloBio LLC of Philadelphia is developing a novel, point-of-care microfluidic chip and reader for rapid platelet function testing. Using minimal amounts of blood, the device will monitor anticoagulation pharmacology used in newborns undergoing corrective heart surgery or on life-sustaining circulatory or pulmonary support. The device will help to control thromboembolic events in infants and children suffering from congenital heart defects. Innovations Unlimited LLC of Pennsauken, N.J. is creating the TrachAlarm to alert pediatric caregivers in a home care or other non-hospital setting if a patient's tracheostomy tube becomes dislodged. Tracheostomy tubes allow patients to breathe while undergoing treatment for certain chronic and congenital diseases. Fast recognition of tracheal dislodgement reduces risk for complications such as hypoxia, respiratory failure, cardiac arrest, and death. The University of Pittsburgh is developing the ThreadRiteIV Catheter to improve the placement of peripheral intravenous catheters. These catheters are widely used for drug delivery in healthcare, but often require multiple attempts for insertion. ThreadRite detects blood vessels through a sophisticated system that measures differences in electrical resistance, and instantaneously alerts the operator of vessel entry via a light, audible, and vibratory signal. This eliminates the dependence on blood return for confirmation of insertion. William J Weiss, PhD, of Penn State College of Medicine is leading efforts to develop the ThoraciCair to reduce the need for invasive and other labor-intensive techniques to treat respiratory distress syndrome in children. The ThoraciCair technology consists of a wearable device to move the chest wall and ventilate the patient by externally applying negative pressure. The ThoraciCair method creates a unique and novel platform for noninvasive ventilation strategies. The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) is seeking information about technical standards and related tools for artificial intelligence (AI). The Request for Information (RFI) is in response to the Feb. 11, 2019, Executive Order on Maintaining American Leadership in Artificial Intelligence , directing NIST to create a plan for federal engagement in the development of these standards and tools in support of reliable, robust, and trustworthy systems that use AI technologies. “Sound technical standards, performance metrics, and tools are needed to foster public trust and confidence in AI technologies,” says Under Secretary of Commerce for Standards and Technology and NIST Director Walter G. Copan. In developing the plan, NIST will engage with other federal agencies, the private sector, academic institutions, nongovernmental organizations, and other stakeholders with an interest and expertise in AI and related standards. Responses to the RFI will help develop a common understanding of the current state, plans, challenges, and opportunities regarding the development and availability of AI technical standards and related tools, as well as federal agencies’ standards-related priorities. “As AI continues to change the way we live and work, robust standards will help ensure understanding and validation of these rapidly evolving technologies,” Copan says. The RFI focuses on three areas: Status of, plans for AI technical standards, related tools development Defining, achieving U.S. leadership in AI standards Prioritizing federal government engagement in AI standardization Topics for which information is requested include: Existing standards and tools Where U.S. is effectively leading standards development Unique needs of the federal government Comments are due by 5 p.m. EDT on May 31, 2019, and may be submitted via email to , or by mail to the National Institute of Standards and Technology, 100 Bureau Drive, Stop 2000, Gaithersburg, MD 20899. Comments will be made publicly available without redaction. To further promote discussions in support of a federal plan for engagement in AI technical standards development, NIST will host a workshop on May 30, 2019, at its Gaithersburg, Maryland, campus. Five pediatric medical device innovators each captured $50K in funding and access to a new pediatric device accelerator program in a competition hosted April 30, 2019 by National Capital Consortium for Pediatric Device Innovation that focused on orthopedic and spine devices. Clockwise from front left: Kolaleh Eskandanian, Children’s National Health System; Cristian Atria, nView Medical; John Barrett, Auctus Surgical Inc.; Paul Mraz, ApiFix; Dan Sands, AMB Surgical II; Anuradha Dayal, BabySteps, Children’s National Health System; Paul Grand, MedTech Innovator; (center) Bill Bentley, Robert E. Fischell Institute for Biomedical Devices, University of Maryland. Photo Credit: Children’s National Health System Advancing pediatric surgical options in orthopedics, spine 5 ‘Make Your Medical Device Pitch for Kids!’ winners share $250,000, access to pediatric device accelerator program. Five winners in The National Capital Consortium for Pediatric Device Innovation’s (NCC-PDI) Make Your Medical Device Pitch for Kids! competition will each receive $50,000 in grant funding and access to the consortium’s Pediatric Device Innovator Accelerator Program led by MedTech Innovator. Winners were selected based on the clinical significance and commercial feasibility of their medical devices for children. The competition focused solely on advancing care in pediatric orthopedics and spine, identified by the U.S. FDA as an emerging, underserved specialty lacking innovation. The winners A device designed to reduce invasive and repetitive surgery in children and teens with orthopedic illnesses such as scoliosis and limb abnormalities Surgical Dynamic Spinal Tethering System, a mechanism used to correct the scoliotic spine in pediatric patients through a tethering procedure Minimally Invasive Deformity Correction (MID-C) System, a posterior dynamic deformity correction system for surgical treatment to provide permanent spinal curve correction while retaining flexibility Platform to improve initial assessment of clubfoot deformity and predict the magnitude of correction Scanner using AI-based image creation to provide instant 3D imaging during surgery to improve imagery speed and accuracy Through the inaugural NCC-PDI “Pediatric Device Innovator Accelerator Program,” MedTech Innovator is providing winners with virtual in-depth, customized mentorship from some of the industry’s leading executives and investors. To learn more about the winners and the fall 2019 pitch competition, visit . Tornos, a manufacturer of CNC single-spindle sliding headstock turning machines for parts less than 36mm diameter; multi-spindle machines with numerical or cam control for parts up to 32mm diameter; and machining centers for complex parts 1dm3 in volume requiring high precision, kicked off a two-day open house with a ribbon cutting ceremony for its new Customer Center outside Chicago. Also coinciding with the company’s 60th anniversary in the U.S., the open house featured industry seminars on medical, automotive, and additional manufacturing sectors. Daniel Maerklin, president of Tornos US welcomed guests to the open house at the customer center, where guest toured a state-of-the-art showroom featuring Tornos’ machine line-up, a large spare parts inventory warehouse, and more accommodating office space for employee growth. Machines on display 7mm new SwissNano US preview Debuted at the event was the 7mm SwissNano model, with kinematics that enable turning, drilling, cutting, deburring, roughing, and finishing operations in higher capacity. While the 4mm bar capacity SwissNano entered medical, micromechanics, electronics, and dental segments, the 7mm accesses larger diameter parts in these markets. Only slightly larger than the standard model, the SwissNano 7mm has a small footprint, is ergonomic, and boasts high thermal stability and precision. Workpiece machining capacity is 7mm x 50mm, spindle output is 2.5kW, standard tools are 18. Supplementary machining functions – thread whirling for main machining operations, gear hobbing, polygon milling, cross-drilling for back-machining operations – have been added. MultiSwiss 8x26 The new variant, the MultiSwiss 8x26 , is designed based on the philosophy and the technology that proved successful on the MultiSwiss 6x14 and MultiSwiss 6x16 machines. The machine features mobile spindles with Z-axis, barrel indexing using torque motor technology, and a container housing all the peripherals required for machine operation. With an optimized machine footprint, the MultiSwiss 8x26 departs from conventional multi-spindle machines, providing the link between multi-spindle and single-spindle turning machines. The machines' on-board technology means it can deliver cycle times equal to those of cam-operated multi-spindle turning machines. MultiSwiss 6x16 The MultiSwiss 6x16 is an easy-to-use machine that has the same footprint as an automatic turning machine with sliding headstock, but is 5x more productive, producing high-quality parts with excellent levels of precision and finishes. SAVE THE DATE:  On Thursday, June 6, 2019 at 2pm, EDT,  BTG Lab’s Dr. Giles Dillingham will offer insight how to surface sensitive inspections and preparations deliver increased bond reliability. Get a review of surface sensitive inspections, a definition of cleanliness for critical applications, a look at variables in medical device surface preparations , and how awareness of these variables permits implementation of simple process control steps that significantly increase bond reliability. Meet your presenter: Dr. Giles Dillingham has worked in the areas of  surfaces, interfaces, and adhesive bonding  for 30 years, and has more than 120 publications and patents in these areas. After receiving his Ph.D. in materials science from the University of Cincinnati in 1987, Dillingham worked in the Advanced Composites Laboratory of the Dow Chemical Co. Returning to Cincinnati he worked on plasma processing of materials and adhesive bonding of advanced composites while incorporating and growing BTG Labs since 2001.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.